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A procedure for determining the extent of phosphorylation at individual sites of multiply
phosphorylated proteins was developed and applied to two polyphosphorylated proteins. The
protocol, using simple chemical (Fischer methyl-esterification) and enzymatic (phosphatase)
modification steps and an accessible isotopic labeling reagent (methyl alcohol-d4), is described
in detail. Site-specific phosphorylation stoichiometries are derived from the comparison of
chemically identical but isotopically distinct peptide species analyzed by microspray liquid
chomatography-mass spectrometry (LC-MS) using a Micromass Q-TOF2 mass spectrometer.
Ten phosphorylation sites were unambiguously identified in tryptic digests of both proteins,
and phosphorylation stoichiometries were determined for eight of the ten sites using the
isotope-coded strategy. The extent of phosphorylation was also estimated from the mass
spectral peak areas for the phosphorylated and unmodified peptides, and these estimates,
when compared with stoichiometries determined using the isotope-coded technique, differed
only marginally (within 20%). (J Am Soc Mass Spectrom 2004, 15, 647–653) © 2004
American Society for Mass SpectrometryProtein phosphorylation is an omnipresent andimportant dynamic phenomenon in living sys-tems that affects protein structure, protein-pro-
tein interactions and catalytic activity during physiolog-
ical processes [1]. Often, protein phosphorylation
occurs simultaneously at many different sites in a single
protein [2, 3]. In these cases it is desirable to learn the
extent to which each site is phosphorylated, to begin to
allow correlation of phosphorylation status to function.
While mass spectrometric (MS) techniques can be
used to great effect in locating and sequencing phos-
phopeptides derived from proteolytic digests of
polyphosphorylated proteins, differences in ionization
and detection efficiencies, from peptide to peptide,
make MS based quantification problematic [4]. Numer-
ous isotopic-coding methodologies have been described
for comparative proteomic applications in the past few
years (reviewed in [5, 6]). A technique utilizing differ-
ential protease-dependent incorporation of 18O/16O,
followed by phosphopeptide enrichment, phosphatase
treatment, and MALDI-MS analysis has been employed
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Zhang and coworkers described using differential
phosphatase treatment and isotope coding to measure
phosphorylation stoichiometry with MALDI-MS analy-
sis [8]. Here we describe an alternative approach, which
combines differential phosphatase treatment with a one
step isotope coding strategy, to yield phosphorylation
site stoichiometries. This method is coupled to micro-
spray liquid chromatography/tandem mass spectro-
metry (LC-MS/MS) to characterize phosphorylation
sites in two poly-phosphorylated proteins from the
Arabidopsis thaliana calcium dependent protein kinase
super-family, CPK1 and CRK3 [9].
We have applied a simple isotopic-coding strategy to
determine the phosphorylation stoichiometry of phos-
phopeptides derived from purified polyphosphory-
lated proteins. The two-part procedure is shown in
Scheme 1. First, a proteolyzed phosphoprotein is ana-
lyzed by LC-MS/MS (Scheme 1a) to identify and
sequence phosphopeptides present in the digest. Sec-
ond, either natural abundance or per-deuterated meth-
anol is used in a bulk Fischer methyl-esterification of
carboxylic acid residues of peptides in the digest to
introduce an isotopic tag, which allows differentiation
between phosphatase treated and untreated peptides
(Scheme 1b). Mass changes resulting from the derivati-r Inc. Received July 9, 2003
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648 HEGEMAN ET AL. J Am Soc Mass Spectrom 2004, 15, 647–653zation and enzymatic treatment are illustrated in
Scheme 2. Part A shows a phosphorylated and unphos-
phorylated peptide pair, and part B indicates the
changes in mass that occur upon differential methyl-
ation and phosphatase treatments.
A simpler stoichiometry calculation may be made by
using the areas of the phosphorylated and unphosphor-
Scheme 1
Scylated peptides in Scheme 2a, but one would need to
assume that the two chemically distinct species have
similar ionization and detection properties. Stoichiom-
etries can be calculated from integrated heavy and light
unphosphorylated peptide peaks in Scheme 2b without
making this assumption, by the comparison of chemi-
cally identical, but isotopically distinct (unlight and
unheavy) species. These measurements are used to test
the validity of the assumption in the direct comparison
of phosphorylated and unphosphorylated peptide peak
volumes for underivatized samples (Scheme 2a) as a
method for estimating phosphorylation site stoichiom-
etries.
Experimental
Protein Purification, Autophosphorylation,
and Proteolysis
All reagents, except where otherwise noted, were ob-
tained from Sigma-Aldrich (St. Louis, MO). Arabidopsis
thaliana CRK3 (at2g46700) and CPK1 (at5g04870) were
expressed in Escherichia coli (DH5) as N-terminal glu-
tathione S-transferase and C-terminal 6  His fusion
proteins to allow purification via the affinity sandwich
method [10]. Briefly, bacterial lysate is passed over a
nickel column (Probond, Invitrogen, Carlsbad, CA),
washed, and eluted with imidazole. The eluent contain-
ing the over-expressed fusion protein is then further
purified on a glutathione Sepharose 4B column, washed
and eluted with glutathione. Proteins were concen-
trated and exchanged into storage buffer (20 mM TRIS-
2heme
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and 1 mM DTT, 5 mM glutathione remains) by
ultrafiltration and frozen prior to subsequent steps.
Each fusion protein was allowed to autophosphorylate
for 40 min at 25 °C in separate 1 mL reaction mixtures
containing 40 g of protein, 20 mM TRIS-HCl pH 7.5, 10
mM MgCl2, 1 mM EGTA, 1.1 mM CaCl2 and 300 M
ATP, additionally, 2–3% glycerol, 200–300 M EDTA
and 200–300 M glutathione were carried over as
components of the enzyme storage buffer (3% and 300
M for CPK1 and 2% and 200 M for CRK3). Protein
was then precipitated by addition of 4 volumes of
acetone and pelletted by centrifugation. The pellets
were suspended each in 40 L of 8 M urea, 1 mM DTT,
and heated to 37 °C for 5 min prior to dilution in 280 L
of 50 mM ammonium bicarbonate pH 7.5, 1 mM DTT.
Proteolysis was then initiated by addition of 0.8 g of
sequencing-grade modified trypsin (Promega, Madi-
son, WI) and continued at 37 °C for 14 h. Half of the
mixture was set aside for the phosphatase treatment/
methyl esterification procedure (Scheme 1b). The re-
maining portion of the digest was terminated by addi-
tion of formic acid to 0.5%, and peptides were purified
by solid phase extraction using a C18-ZipTip (Millipore,
Billerica, MA) for subsequent LC-MS and LC-
MS/MS analyses.
LC-MS and MS/MS
A portion of each purified digest, corresponding to 10
g (120 pmoles) of pre-digested protein, was analyzed
by LC-MS/MS using a Micromass Q-TOF2 spectrom-
eter to locate phosphorylation sites (Scheme 1a). Chro-
matographic separation of peptides prior to mass spec-
tral analysis was accomplished using C18 reverse phase
HPLC columns made in-house from which eluted spe-
cies are directly micro-electrosprayed [11]. Columns
were made using lengths of fused silica tubing (365 m
o.d., 100 m i.d.) with pulled tips (1 m orifice) that
were packed to 12 cm with Zorbax Eclipse XDB-C18, 5
m, 300 Å pore size media. An Agilent 1100 series
HPLC (Palo Alto, CA) delivered solvents A: 0.1% (vol/
vol) formic acid in water, and B: 95% (vol/vol) aceto-
nitrile, 0.1% (vol/vol) formic acid at either 1 L/min for
sample application, or 150–200 nL/min during a 200
min 2% (vol/vol) B to 70% (vol/vol) B gradient. Voltage
was applied upstream of the column, by introduction of
a platinum wire electrode into the fluid path via a PEEK
T-junction. As peptides eluted from the HPLC-column/
electrospray source, MS/MS spectra were collected
over four channels from 400 to 1500 m/z; redundancy
was limited by dynamic exclusion. Charge dependent
collision energy profiles were empirically pre-deter-
mined. MS/MS data were converted to pkl file format
using MassLynx version 3.5 (Micromass, Waters, Mil-
ford, MA). Resulting pkl files were used to search a
modified Arabidopsis thaliana database containing both
fusion-protein amino acid sequences using Mascot (Ma-trix Science, London, UK) with methionine oxidation
and serine and threonine phosphorylation as variable
modifications. Putative phosphopeptides identified by
Mascot were confirmed and sequences were assigned to
MS/MS spectra manually. The remaining 10 g of each
digest was analyzed by LC-MS (same gradient and
conditions as above) to allow integration of uninter-
rupted ion current for the direct comparison of phos-
phorylated and unphosphorylated peptide signals.
Phosphorylation Site Stoichiometry Determination
As outlined in Scheme 1b, half of each autophosphory-
lated CPK1 and CRK3 fusion protein digest was split
additionally into two tubes (each with 10 g, 120
pmoles of digested protein). One of the two aliquots for
each protein was treated with 10 units of calf intestinal
alkaline phosphatase (New England Biolabs, Beverly,
MA) with addition of the manufacturer’s buffer, for 14 h
at 37 °C while the other aliquot was not. Both aliquots
for each protein were lyophilized and then differen-
tially isotopically labeled by bulk Fischer esterification
in either natural abundance- or deutero-methanol that
is 2 M in anhydrous HCl. The esterification protocol is
essentially that described by Ficarro and coworkers
[12], where HCl is generated in situ by addition of
acetylchloride to the methanol, on ice, with stirring,
prior to its addition to the peptide mixture. The reaction
was allowed to proceed for 2 h at room temperature at
which point the methanol was removed under vacuum
(Savant Speed Vac, GMI, Albertville, MN). As a modi-
fication of the Ficarro protocol, the sample was resus-
pended in methanol (using the same isotopic form as
originally used) and evaporated again to remove as
much HCl as possible. The samples were resuspended
in methanol a second time, and sodium bicarbonate was
added until CO2 generation ceased, indicating neutral-
ization of the HCl. (Removal of HCl is critical to prevent
ester hydrolysis prior to addition of aqueous solvents.)
Methanol was then removed and the residue was
resuspended in 0.5% formic acid in water (formic acid
should be added in excess of remaining bicarbonate to
ensure sample acidification). Peptides were purified by
sold phase extraction using C18-ZipTips (Millipore),
and heavy and light methylated samples were com-
bined prior to LC-MS analysis as described above.
Data Analysis
Methylated and deuteromethylated peptide m/z values
(for 1, 2, 3, and 4) were calculated for each
phosphorylated and unphosphorylated peptide pair
identified, and confirmed from the LC-MS/MS anal-
ysis. The anticipated mass shifts resulting from phos-
phatase treatment and the isotopically coded (methyl)
esterification are detailed in Scheme 2. Signal intensities
were determined by generating composite spectra dur-
650 HEGEMAN ET AL. J Am Soc Mass Spectrom 2004, 15, 647–653ing peptide elution, and transforming a region covering
each charge state independently using the MaxEnt3
algorithm (Micromass) to deisotope, centroid and con-
vert m/z to mass. Peak intensities were recorded for all
observed calculated masses and isotopic pairs were
corrected for mixing error as determined by the average
ratio of 10 (CRK3) and 20 (CPK1) peptide pairs corre-
sponding to unphosphorylated portions of each pro-
tein. The phosphorylation stoichiometry was calculated
for each site using the corrected values for unphosphor-
ylated peptide isotopic pair via the formula: % phos-
phorylation  (unheavy  unlight)/unheavy  100%. The
percentages determined for each charge state were
treated as independent measurements and averaged to
generate the percentage and error values. The complete-
ness of the phosphatase treatment was assessed for each
site using the corrected values for phosphorylated pep-
tide isotopic pair via the formula: % dephosphorylation
 phoslight/(phosheavy  phoslight)  100%.
Results and Discussion
Two polyphosphorylated proteins, autophosphorylated
CPK1 and CRK3, were trypsinized and subjected to
LC-MS/MS analysis resulting in the identification of
six phosphopeptides in each protein. The exact phos-
phorylated residues were identified by manual assign-
ment of MS/MS data for all six unique sites for CPK1
and four of five unique sites for CRK3. The peptide
sequences and phosphorylation sites are shown in
Table 1. Sequence coverage from the analysis of the
trypsin digests of 10 g (120 pmoles) of protein was
68% for both kinase constructs. Quality and extent of
coverage decreases as the amount of analyte is reduced,
with less than 40% coverage expected for 1 g (ap-
proaching 10 pmoles) of the same sample providing a
practical limit for sensitivity at this step. Once phos-
Table 1. AtCPK1 and AtCRK3 phosphorylation sites and stoich
Protein Site in protein Phosp
AtCPK1 S18 NGFLQSVpSAAMW
T64 LSDEVQNKPPEQVp
S83 TEpSKPETLEEISLES
T107 SEpTKPESKPDPPAK
S137 TEpSVLQR
S151 KTENFKEFYpSLGR
AtCRK3 S65 SSNPSPWFSPFPHG
S132 GTEPEQSLDKpSFG
T280, S281 or S282 DLKPENFLF*T*S*S
T280, S281 or S282 DLKPENFLF*T*S*S
S311 LNDIVGpSAYYVAP
S353 TEpSGIFR
*The marked serine and threonine residues indicate ambiguity in the a
phosphorylated site in the intact AtCRK3 protein.
aThis phosphopeptide was only partially dephosphorylated, and s
phosphorylated and dephosphorylated pairs.
bErrors for percentages determined by direct comparison are at least 1phorylation sites have been characterized, the sensitiv-
ity limits for detection of unfragmented derivatized and
underivatized peptides are less restricted (realistically 1
pmole to 100 fmoles), as they do not rely on assignment
of tandem mass spectral data, although we have not
explicitly tested these limits in this initial study. Tan-
dem MS data were obtained for each phosphopeptide
identified and the fragmentation spectra were manually
assigned (data not shown); in two of the peptides the
precise location of the phosphorylation was ambiguous.
Phosphorylation stoichiometry was determined for
five of the six peptides from each protein using the
isotopic-coding technique described herein. Percent
phosphorylation is listed for each site in the table under
the “Using isotopic-coding” heading. The derivatiza-
tion protocol apparently altered the physical properties
of the two unanalyzed peptides so that they could not
be detected under the analysis conditions. Figure 1
shows mass spectra of a CRK3 tryptic peptide (LNDI-
VGpSAYYVAPEVLHR) without (Figure 1a) and with
(Figure 1b) the application of the isotopic-coding tech-
nique. Part A shows the underivatized phosphorylated
and unphosphorylated peptide peaks. For each case in
this study the phosphorylated peptide eluted before the
unphosphorylated species. Figure 1b shows the same
peptides after differential phosphatase treatment and
derivatization. As shown in the inset elution profiles
(Figure 1b), deuterium isotope effects observed with the
unphosphorylated methyl esterified isotopic pairs, in
all ten observed cases, resulted in the deuterated species
eluting slightly prior to the proteated species. The
absence of a heavy isotope species of the phosphory-
lated species (see arrow) shows that the phosphatase
treatment was complete. This was the case for all of the
peptides observed except for the LSDEVQNK-
PPEQVpTMPKPGTDVETK peptide for which dephos-
try
ptide
% Phosphorylation
Using isotopic-
coding
Using direct
comparisonb
none detected 90%
KPGTDVETK 68 (7)%a 79%
TK 59 (2)% 57%
23 (2)% 19%
76 (2)% 54%
62 (3)% 63%
SPLPSGVSPAPAR none detected 37%
80 (3)% 100%
60 (7)% 24%
DLK 95 (7)% 100%
R 59 (3)% 63%
96.8 (0.3)% 93%
ment of the phosphorylation site. These two peptides cover the same
percentage listed was calculated using the combination of bothiome
hope
RPR
TMP
KPE
PK
pSA
YGK
R
REDS
EVLH
ssign
o the
0%.
651J Am Soc Mass Spectrom 2004, 15, 647–653 PROTEIN PHOSPHORYLATION STOICHIOMETRYFigure 1. Two ways to determine the phosphorylation stoichiometry of a partially phosphorylated
CRK3 tryptic peptide (LNDIVGpSAYYVAPEVLHR). (a) Direct comparison of peptide with and
without phosphorylation. The spectrum is the sum of all spectra collected over both peaks in the inset
selected-ion elution profile. (b) Differential phosphatase treatment followed by methyl-ester isotope
coding. Methylation occurs at three carboxylic acid moieties in this peptide: the C-terminus; and two
side chains [LND(CH3)IVGpSAYYVAPE(CH3)VLHR-(CH3)]. Phosphorylation stoichiometry is deter-
mined from the difference in intensities of the unphosphorylated 3(CH3) and 3(CD3) derivatized
peptide peaks. The modified peptides are isotopically distinct but chemically identical and have the
same ionization and detection properties while being easily distinguished by mass difference. The
phosphatase treatment has resulted in the complete conversion of the phosphorylated 3(CD3) to
unphosphorylated 3(CD3) peptide as indicated by the arrow on the right side of the spectrum. Both
spectra are the sum of all spectra over each inset selected-ion elution profile.
652 HEGEMAN ET AL. J Am Soc Mass Spectrom 2004, 15, 647–653phorylation was only 54% complete. The value listed
for this peptide in the table was derived by correcting
for the measured percent dephosphorylation. This pep-
tide was also only observed with a single methionine
oxidation. The Fischer esterification was quantitative
with no peaks assignable to partial derivatization prod-
ucts as was the case for all ten peptides observed using
this method (data not shown). Complete removal of
HCl is critical to prevent ester hydrolysis upon addition
of aqueous solvent (see modifications to the procedure
of Ficarro et al. [12] described in the Experimental
section).
Two of the peptides with ambiguous phosphoryla-
tion sites overlap because of a missed cleavage. For both
of these peptides, phosphorylation appears to occur at
one of three adjacent residues in a “TSS” motif. As the
digests were largely complete, it is likely that missed
cleavage results from phosphorylation of the serine
residue immediately prior to the arginine residue block-
ing proteolysis. A missed cleavage event will interfere
with the ultimate goal of assigning a phosphorylation
stoichiometry for a specific site in the protein. In these
cases it is impossible to meaningfully combine the
stoichiometries determined for the individual overlap-
ping peptides to determine a stoichiometry for the site.
Because of this, neither peptide is included in subse-
quent data analysis. All of the other stoichiometry
measurements in this study were from unique and fully
trypsinized peptides, which provided useful informa-
tion about the site stoichiometry for the intact polypep-
tide chain.
If one assumes that the modification of a peptide by
phosphorylation has no significant effect on its ioniza-
tion and detection properties during MS analysis, it
would then be reasonable to compare the two species
directly to obtain phosphorylation stoichiometries [13].
To test this assumption, phosphorylated and unphos-
phorylated peptide peak areas were determined, and
used to calculate the per cent phosphorylation for each
phosphopeptide identified in the CPK1 and CRK3 di-
gests. Phosphorylation stoichiometries determined us-
ing direct comparison are listed in the table under the
“Using direct comparison” heading. When these mea-
surements are compared to the values obtained using
the isotopic coding strategy, (not including the two
CRK3 peptides with ambiguous phosphorylation sites
and partial proteolysis) all eight peptides were within
22% of the isotope coded values, and five were within
4%. No correlation was evident between the discrep-
ancy in the two values and total ion current during
phosphorylated and unphosphorylated peptide peak
elution. Within the scope of this sample, the ionization
and detection efficiencies are similar enough for a given
phosphorylated and unphosphorylated species to allow
the phosphorylation stoichiometry to be estimated to
within 20% of the values determined for chemically
identical species.Conclusions
An isotope-coding method for determining site specific
phosphorylation stoichiometries for polyphosphory-
lated proteins has been described in detail and applied
to two proteins. Tryptic digests of these proteins to-
gether contained twelve phosphopeptides, two of
which could not be analyzed as the esterified peptides
were not observed. While the 17% failure rate is a
drawback for this technique, the relative ease of the
procedure and availability (and affordability) of the
isotopic and other reagents are an advantage. An even
simpler approach, comparing the peak areas of a phos-
phopeptide and its unphosphorylated form, yielded
stoichiometry estimates to within 20% of the isotope-
coded results. This demonstrates that the direct com-
parison of phosphorylated and unphosphorylated pep-
tide peak intensities is reasonable means of estimating
phosphorylation stoichiometries. Differential phospha-
tase treatment followed by Fisher methyl esterification
with CH3OH or CD3OH provides a simple technique
for determining protein phosphorylation stoichiome-
tries when more precision is required.
Acknowledgments
This work was supported by a grant from the National Science
Foundation 2010 Project (MCB-0114769). The authors thank Drs.
Catherine W. M. Chan, John C. Cushman, Alice C. Harmon, and
Estelle M. Hrabak for helpful advice and valuable discussions.
References
1. Johnson, L. N.; Lewis, R. J. Structural Basis of Control by
Phosphorylation. Chem. Rev 2001, 101, 2209–2242.
2. Chen, S. L.; Huddleston, M. J.; Shou, W.; Deshaies, R. J.;
Annan, R. S.; Carr, S. A. Mass Spectrometry-Based Methods
for Phosphorylation Site Mapping of Hyperphosphorylated
Proteins Applied to Net1, a Regulator of Exit from Mitosis in
Yeast. Mol. Cell. Proteom 2002, 1, 186–196.
3. Radimerski, T.; Mini, T.; Schneider, U.; Wettenhall, R. E. H.;
Thomas, G.; Jeno¨, P. Identification of Insulin-Induced Sites of
Ribosomal Protein S6 Phosphorylation in Drosophila melano-
gaster. Biochemistry 2000, 39, 5766–5774.
4. Mann, M.; Ong, S.-E.; Grønborg, M.; Steen, H.; Jensen, O. N.;
Pandey, A. Analysis of Protein Phosphorylation Using Mass
Spectrometry: Deciphering the Phosphoproteome. Trends Bio-
technol 2002, 20, 261–268.
5. Goshe, M.B.; Smith, R. D. Stable Isotope-Coded Proteomic
Mass Spectrometry. Curr. Opin. Chem. Biol 2003, 14, 101–109.
6. Tao, W. A.; Aebersold, R. Advances in Quantitative Proteom-
ics via Stable Isotope Tagging and Mass Spectrometry. Curr.
Opin. Chem. Biol 2003, 14, 110–118.
7. Bonenfant, D.; Schmelzle, T.; Jacinto, E.; Crespo, J. L.; Mini, T.;
Hall, M. N.; Jenoe, P. Quantitation of Changes in Protein
Phosphorylation: A Simple Method Based on Stable Isotope
Labeling and Mass Spectrometry. Proc. Nat. Acad. Sci. U.S.A
2003, 100(3), 880–885.
8. Zhang, X.; Jin, Q. K.; Carr, S. A.; Annan, R. S. N-Terminal
Peptide Labeling Strategy for Incorporation of Isotopic Tags:
653J Am Soc Mass Spectrom 2004, 15, 647–653 PROTEIN PHOSPHORYLATION STOICHIOMETRYA Method for the Determination of Site-Specific Absolute
Phosphorylation Stoichiometry. Rapid Commun. Mass Spectrom
2002, 16, 2325–2332.
9. Harmon, A. C.; Gribskov, M.; Gubrium, E.; Harper, J. F. The
CDPK Family of Protein Kinases. New Physiolog 2001, 151,
175–183.
10. Harper, J. F.; Huang, J.-F.; Lloyd, S. J. Genetic Identification of
an Autoinhibitor in CDPK, a Protein Kinase with a Calmod-
ulin-Like Domain. Biochemistry 1994, 33, 7267–7277.
11. Gatlin, C. L.; Kleemann, G. R.; Hays, L. G.; Link, A. J.; Yates,
J. R. Protein Identification at the Low Femptomole Level fromSilver Stained Gels Using a New Fritless Electrospray Interface
for Liquid Chromatography Microspray and Nanospray Mass
Spectrometry. Anal. Biochem 1998, 263, 93–101.
12. Ficarro, S. B.; McCleland, M. L.; Stukenberg, P. T.; Burke, D. J.;
Ross, M. M.; Shabanowitz, J.; Hunt, D. F.; White, F. M.
Phosphoproteome Analysis by Mass Spectrometry and its
Application to Saccharomyces cerevisiae. Nat. Biotechnol 2002,
20, 301–305.
13. Resing, K. A.; Ahn, N. G. Protein Phosphorylation Analysis by
Electrospray Ionization-Mass Spectrometry. Methods Enzymol
1997, 283, 29–44.
